Published on in Vol 22, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19694, first published .
Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

Journals

  1. Westeel V, Bourdon M, Cortot A, Debieuvre D, Toffart A, Acquadro M, Arnould B, Lambert J, Cotte F, Gaudin A, Lemasson H. Management of lung cancer patients' quality of life in clinical practice: a Delphi study. ESMO Open 2021;6(4):100239 View
  2. Renner S, Marty T, Khadhar M, Foulquié P, Voillot P, Mebarki A, Montagni I, Texier N, Schück S. A New Method to Extract Health-Related Quality of Life Data From Social Media Testimonies: Algorithm Development and Validation. Journal of Medical Internet Research 2022;24(1):e31528 View
  3. Wilczynski O, Boisbouvier A, Radoszycki L, Cotté F, Gaudin A, Lemasson H. Integrating Quality of Life in the Care Pathway of Cancer Patients Undergoing Immunotherapy Treatment: Descriptive, Cross-sectional Survey of an Online Patient Community's Experiences and Expectations. Journal of Medical Internet Research 2022;24(1):e25792 View
  4. Kalf R, Delnoij D, Ryll B, Bouvy M, Goettsch W. Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study. Journal of Medical Internet Research 2021;23(12):e27497 View
  5. Renner S, Loussikian P, Foulquié P, Marrel A, Barbier V, Mebarki A, Schück S, Bharmal M. Patient and Caregiver Perceptions of Advanced Bladder Cancer Systemic Treatments: Infodemiology Study Based on Social Media Data. JMIR Cancer 2023;9:e45011 View
  6. Grumberg V, Chouaïd C, Gaudin A, Le Tourneau C, Marabelle A, Bongiovanni-Delarozière I, Cotté F, Borget I. Organizational Impact of Immunotherapies in Advanced Cancers in France. JCO Global Oncology 2023;(9) View
  7. Meadows K, Reaney M. Story completion (SC) – an epistemological approach to the interpretation of patient-reported outcomes?. Expert Review of Pharmacoeconomics & Outcomes Research 2024;24(1):49 View
  8. Wang H, Dong Y, Fan T, Zhu S, Zhou Y, Song Y, Pan S, Wu Q, Li Y, Han Y. Health-related quality of life and its influencing factors among lung cancer patients receiving immune checkpoint inhibitors: A cross-sectional study. European Journal of Oncology Nursing 2024;68:102507 View
  9. Cimiano P, Collins B, De Vuono M, Escudier T, Gottowik J, Hartung M, Leddin M, Neupane B, Rodriguez-Esteban R, Schmidt A, Starke-Knäusel C, Voorhaar M, Wieckowski K. Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators. Frontiers in Medicine 2024;11 View